Bayer and biotech Onyx Pharmaceuticals announced a devastatingly disappointing result for their cancer pill Nexavar: They stopped a study of the drug in non-small cell lung cancer early because there was no chance it would reach its main goal of proving Nexavar extends patients' lives in that disease.
Link to Article
Forbes.com
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Tuesday, February 19
Questions For Onyx Pharmaceuticals
by
Alex Hsieh on behalf of Professor Henry Wang
on Tue 19 Feb 2008 10:27 PM EST
FDA evaluated wrong Chinese drug factory
by
Alex Hsieh on behalf of Professor Henry Wang
on Tue 19 Feb 2008 10:24 PM EST
|
Search
Links
|
||